Pin Wang
45 Changchun Street
Beijing, 100053, China
Beijing, 100053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Plasma Phosphorylated Tau217-A Pivotal Plasma Biomarker for Predicting the Progression of Mild Cognitive Impairment to Alzheimer's Disease: A Reanalysis of ADNI Data.
Journal: Journal of clinical and experimental neuropsychology
Published: May 12, 2026
Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 03, 2025
Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18F-FDG-PET.
Journal: AJNR. American journal of neuroradiology
Published: August 18, 2025
Cognitive Function and Proteomic Changes in Patients with Autoantibody-Positive Neurodegenerative Dementia.
Journal: Neurology and therapy
Published: July 09, 2025
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons.
Journal: Journal of Alzheimer's disease : JAD
Published: June 23, 2025
Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: November 14, 2024
Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial.
Journal: Psychiatry and clinical neurosciences
Published: October 16, 2024
Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: August 30, 2024
Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study).
Journal: BMJ open
Published: July 13, 2024
Extensive perivascular spaces burden causally affects neurodegenerative diseases and brain structure: A two-sample bidirectional Mendelian randomization study.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: July 01, 2024
Circulating adipokines level and the risk of neurodegenerative diseases: a two‑sample mendelian randomization study and proteomic analysis.
Journal: BMC neurology
Published: June 11, 2024
Last Updated: 09/26/2026